GGrantIndex
← Leaderboards

Jessica E Thaxton

Univ Of North Carolina Chapel Hill

$4,123,586
Attributed
$4,123,586
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $781.4K · FY202025
$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,123,586 · 3

By mechanism

R01$4,123,586 · 3

Top collaborators

No co-investigators on record.

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Tumor

Research focus

TumorResponseCancer PatientCd8b1 GeneStressImmunotherapyT-LymphocyteSarcomaMolecular TargetMetabolicSolid NeoplasmSensorShapesGeneticCellsPhosphotransferasesMolecularCell PhysiologyMetabolomicsEndoplasmic ReticulumEndoplasmic Reticulum StressChronicAcuteBiological Adaptation To Stress

Grant awards (14)

Manipulating Lipid Metabolism to Reverse Immune Dysfunction in Solid Cancers$496,391
R01 · FY2025 · CA · contact PI
Expoitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy$335,255
R01 · FY2024 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$332,665
R01 · FY2024 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$82,870
R01 · FY2024 · CA · contact PI
Expoitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy$348,592
R01 · FY2023 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$345,558
R01 · FY2023 · CA · contact PI
ATF4 As A Driver of T Cell Inefficacy in Tumors$87,216
R01 · FY2023 · CA · contact PI
Expoitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy$355,706
R01 · FY2022 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$349,947
R01 · FY2022 · CA · contact PI
Exploitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy$341,981
R01 · FY2021 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$206,758
R01 · FY2021 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$150,385
R01 · FY2021 · CA · contact PI
Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy$348,281
R01 · FY2020 · CA · contact PI
Exploitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy$341,981
R01 · FY2020 · CA · contact PI